HPS-090 - Prognostic factors and survival analysis in Acute Myeloid Leukemia (AML) patients: A retrospective study from 2016 to 2024

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-090
• By: CHU, Li-ling (ChiMei Medical Center, China Taiwan)
• Co-author(s): Mrs Li-ling Chu (ChiMei Medical Center, Tainan, China Taiwan)
  Mrs Hui-Chen Su
  
• Abstract:

  Background
  Acute myeloid leukemia (AML) is a hematologic malignancy with highly variable survival outcomes influenced by patient-specific factors such as age, initial laboratory values, treatment approaches, and genetic mutations. Certain genetic mutations are known to contribute to treatment resistance and relapse, making genetic profiling an..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login